Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8JF4

The crystal structure of human AURKA kinase domain in complex with AURKA-compound 9

8JF4 の概要
エントリーDOI10.2210/pdb8jf4/pdb
分子名称Aurora kinase A, 2-[4-[4-[bis(oxidanylidene)-$l^5-sulfanyl]oxyphenyl]carbonylpiperazin-1-yl]-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-N-prop-2-ynyl-pyrimidine-4-carboxamide (2 entities in total)
機能のキーワードlysine inhibitor, cytokine
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計31115.71
構造登録者
Zhu, C.J. (登録日: 2023-05-17, 公開日: 2024-02-14, 最終更新日: 2024-03-27)
主引用文献Tang, G.,Wang, W.,Zhu, C.,Huang, H.,Chen, P.,Wang, X.,Xu, M.,Sun, J.,Zhang, C.J.,Xiao, Q.,Gao, L.,Zhang, Z.M.,Yao, S.Q.
Global Reactivity Profiling of the Catalytic Lysine in Human Kinome for Covalent Inhibitor Development.
Angew.Chem.Int.Ed.Engl., 63:e202316394-e202316394, 2024
Cited by
PubMed Abstract: Advances in targeted covalent inhibitors (TCIs) have been made by using lysine-reactive chemistries. Few aminophiles possessing balanced reactivity/stability for the development of cell-active TCIs are however available. We report herein lysine-reactive activity-based probes (ABPs; 2-14) based on the chemistry of aryl fluorosulfates (ArOSO F) capable of global reactivity profiling of the catalytic lysine in human kinome from mammalian cells. We concurrently developed reversible covalent ABPs (15/16) by installing salicylaldehydes (SA) onto a promiscuous kinase-binding scaffold. The stability and amine reactivity of these probes exhibited a broad range of tunability. X-ray crystallography and mass spectrometry (MS) confirmed the successful covalent engagement between ArOSO F on 9 and the catalytic lysine of SRC kinase. Chemoproteomic studies enabled the profiling of >300 endogenous kinases, thus providing a global landscape of ligandable catalytic lysines of the kinome. By further introducing these aminophiles into VX-680 (a noncovalent inhibitor of AURKA kinase), we generated novel lysine-reactive TCIs that exhibited excellent in vitro potency and reasonable cellular activities with prolonged residence time. Our work serves as a general guide for the development of lysine-reactive ArOSO F-based TCIs.
PubMed: 38248139
DOI: 10.1002/anie.202316394
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.89288354365 Å)
構造検証レポート
Validation report summary of 8jf4
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon